Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
journalStr:"BMC cancer"
format_facet:"Elektronische Ressource"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22BMC+cancer%22&filter%5B%5D=format_facet%3A%22Elektronische+Ressource%22&lookfor=%22Rimassa%2C+Lorenza%22&type=Person
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22BMC+cancer%22&filter%5B%5D=format_facet%3A%22Elektronische+Ressource%22&lookfor=%22Rimassa%2C+Lorenza%22&type=Person
Search /vufind/Search2/Results?filter%5B%5D=journalStr%3A%22BMC+cancer%22&filter%5B%5D=format_facet%3A%22Elektronische+Ressource%22&lookfor=%22Rimassa%2C+Lorenza%22&type=Person
PubPharm (16)
1
Correction to : A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY tract cancers (BTC) at high risk for recurrence: PURITY study
enthalten in:
BMC cancer
| 2024
von
Niger, M.
|
Nichetti, F.
|
Fornaro, L.
| +34
ErratumFor: BMC Cancer. 2024 Apr 8;24(1):436. - PMID 38589856
Wird geladen...
2
Correction to: A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY tract cancers (BTC) at high risk for recurrence: PURITY study
enthalten in:
BMC cancer
| 2024
von
Niger, M.
|
Nichetti, F.
|
Fornaro, L.
| +34
Wird geladen...
3
A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY Tract Cancers (BTC) at high risk for recurrence : PURITY study
enthalten in:
BMC cancer
| 2024
von
Niger, M.
|
Nichetti, F.
|
Fornaro, L.
| +34
ErratumIn: BMC Cancer. 2024 May 6;24(1):563. - PMID 38711003
Wird geladen...
4
A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY Tract Cancers (BTC) at high risk for recurrence: PURITY study
enthalten in:
BMC cancer
| 2024
von
Niger, M.
|
Nichetti, F.
|
Fornaro, L.
| +34
Wird geladen...
5
Safety and efficacy of cabozantinib for patients with advanced hepatocellular carcinoma who advanced to Child-Pugh B liver function at study week 8 : a retrospective analysis of the CELESTIAL randomised controlled trial
enthalten in:
BMC cancer
| 2022
von
El-Khoueiry, A.
|
Meyer, T.
|
Cheng, A.
| +5
Wird geladen...
6
Safety and efficacy of cabozantinib for patients with advanced hepatocellular carcinoma who advanced to Child–Pugh B liver function at study week 8: a retrospective analysis of the CELESTIAL randomised controlled trial
enthalten in:
BMC cancer
| 2022
von
El-Khoueiry, A.
|
Meyer, T.
|
Cheng, A.
| +5
Wird geladen...
7
Safety and efficacy of cabozantinib for patients with advanced hepatocellular carcinoma who advanced to Child–Pugh B liver function at study week 8: a retrospective analysis of the CELESTIAL randomised controlled trial
enthalten in:
BMC cancer
| 2022
von
El-Khoueiry, A.
|
Meyer, T.
|
Cheng, A.
| +5
Wird geladen...
8
Assessment of Ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line chemotherapy in patients with advanced HER-2 negative gastric or gastroesophageal junction cancers : the ARMANI phase III trial
enthalten in:
BMC cancer
| 2019
von
Di Bartolomeo, M.
|
Niger, M.
|
Morano, F.
| +36
Wird geladen...
9
Assessment of Ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line chemotherapy in patients with advanced HER-2 negative gastric or gastroesophageal junction cancers: the ARMANI phase III trial
enthalten in:
BMC cancer
| 2019
von
Di Bartolomeo, M.
|
Niger, M.
|
Morano, F.
| +36
Wird geladen...
10
Assessment of Ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line chemotherapy in patients with advanced HER-2 negative gastric or gastroesophageal junction cancers: the ARMANI phase III trial
enthalten in:
BMC cancer
| 2019
von
Di Bartolomeo, M.
|
Niger, M.
|
Morano, F.
| +36
Wird geladen...
1
2
Nächster »
[2]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Zeitschrift: BMC cancer
Filter aufheben
Medienart: E-Ressourcen
Medienart
16
Aufsätze
16
E-Artikel
E-Ressourcen
Zeitschriftentitel
BMC cancer
Thema
5
Journal Article
3
Cabozantinib
3
Child–Pugh B
3
Clinical trial
3
First line
3
Hepatocellular carcinoma
3
Maintenance
3
Metastatic gastric cancer
3
Ramucirumab
2
Biliary tract cancers
2
Cholangiocarcinoma
2
Cisplatin gemcitabine nabpaclitaxel
2
Clinical Trial, Phase III
2
Colorectal oligometastases
2
Gastric Carcinoma
2
Hard Palate
2
Liver
2
Lung
2
Multicenter Study
2
Neoadjuvant chemotherapy
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
7
2020-
6
2010-2019
3
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
16
Englisch
Haven't found what you're looking for?
Wird geladen...